FDA Votes To Remove Avastin From Approved Breast Cancer Drugs
One of the most prescribed breast cancer medications may soon no longer be available for patients who receive the diagnosis. A special panel of the U.S. Food and Drug Administration voted Wednesday to recommend that Avastin no longer be an approved label for the treatment of breast cancer.